Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-11-18

Clinical Trial Update: Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ultra-long versus long down-regulation protocols in IVF/ICSI for adenomyosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Adenomyosis | Phase 3 | Status: WITHDRAWN